Search Results - "Moses, Shimon"

Refine Results
  1. 1

    The variable presentations of glycogen storage disease type IV: a review of clinical, enzymatic and molecular studies by Moses, Shimon W, Parvari, Ruti

    Published in Current molecular medicine (01-03-2002)
    “…Glycogen storage disease type IV (GSD-IV), also known as Andersen disease or amylopectinosis (MIM 23250), is a rare autosomal recessive disorder caused by a…”
    Get more information
    Journal Article
  2. 2

    The percentage of patients achieving PASI 75 after 1 month and remission time after climatotherapy at the Dead Sea by Harari, Marco, Novack, Lena, Barth, Joachim, David, Michael, Friger, Michael, Moses, Shimon W.

    Published in International journal of dermatology (01-10-2007)
    “…Background  Dead Sea climatotherapy (DSC) is a highly effective treatment for psoriasis; however, there are scanty data concerning the duration of post‐therapy…”
    Get full text
    Journal Article
  3. 3

    Historical highlights and unsolved problems in glycogen storage disease type 1 by Moses, Shimon W

    Published in European journal of pediatrics (01-10-2002)
    “…Thirty-three years after Von Gierke described the first patient with glycogen storage disease type 1 (GSD1) in 1929, the Coris detected glucose-6-phosphatase…”
    Get full text
    Journal Article
  4. 4

    Impact of descent and stay at a Dead Sea resort (low altitude) on patients with systolic congestive heart failure and an implantable cardioverter defibrillator by Gabizon, Isack, Shiyovich, Arthur, Novack, Victor, Khalameizer, Vladimir, Yosefy, Chaim, Moses, Shimon W, Katz, Amos

    Published in The Israel Medical Association journal (01-07-2011)
    “…As the lowest natural site on earth (-415 meters), the Dead Sea is unique for its high pressure and oxygen tension in addition to the unparalleled combination…”
    Get full text
    Journal Article
  5. 5

    Historical highlights and unsolved problems in glycogen storage disease type 1 by Moses, Shimon

    Published in European journal of pediatrics (01-01-2002)
    “…Thirty-three years after Von Gierke described the first patient with glycogen storage disease type 1 (GSD1) in 1929, the Coris detected glucose-6-phosphatase…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Inactivation of the Glucose 6-Phosphate Transporter Causes Glycogen Storage Disease Type 1b by Hiraiwa, H, Pan, C J, Lin, B, Moses, S W, Chou, J Y

    Published in The Journal of biological chemistry (26-02-1999)
    “…Glycogen storage disease type 1b (GSD-1b) is proposed to be caused by a deficiency in microsomal glucose 6-phosphate (G6P) transport, causing a loss of…”
    Get full text
    Journal Article
  9. 9

    Neurophysiologic studies in congenital insensitivity to pain with anhidrosis by Shorer, Zamir, Moses, Shimon W, Hershkovitz, Eliahu, Pinsk, Vered, Levy, Jacov

    Published in Pediatric neurology (01-11-2001)
    “…Thirteen patients with congenital insensitivity to pain and anhidrosis, carrying a mutation at the TRK-A gene, were studied. Neurologic examination revealed…”
    Get full text
    Journal Article
  10. 10

    A Single-Base Deletion in the 3'-Coding Region of Glycogen-Debranching Enzyme Is Prevalent in Glycogen Storage Disease Type IIIA in a Population of North African Jewish Patients by Parvari, Ruti, Moses, Shimon, Shen, Jianjun, Hershkovitz, Eli, Lerner, Aaron, Chen, Yuan-Tsong

    Published in European journal of human genetics : EJHG (01-09-1997)
    “…Glycogen storage disease type III (GSD III) is an autosomal recessive disease caused by the deficiency of glycogen-debranching enzyme (AGL). The overall…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Health Effects of Dead Sea Climatotherapy on Patients with Heart and Lung Diseases/Efectos saludables de la Climatoterapia del Mar Muerto en pacientes con enfermedades cardíacas y pulmonares by Moses, Shimon W

    Published in Anales de hidrología médica (01-01-2012)
    “…The Dead Sea (Sea of Salt in Hebrew), the lowest saline lake on earth, contains high concentrations of salts and is a reservoir of minerals with a unique…”
    Get full text
    Journal Article
  13. 13

    Glycogen storage disease type III in Israel: presentation and long-term outcome by Hershkovitz, Eli, Forschner, Itay, Mandel, Hanna, Spiegel, Ronen, Lerman-Sagie, Tally, Anikster, Yair, Zeharia, A, Moses, Shimon

    Published in Pediatric endocrinology reviews : PER (01-03-2014)
    “…Glycogen storage disease type III (GSD III) was found in the past with an unusual frequency among North African Jews in Israel. The aim of this study was to…”
    Get more information
    Journal Article
  14. 14
  15. 15

    Hexose uptake and transport in polymorphonuclear leukocytes from patients with glycogen storage disease Ib by Potashnik, R, Moran, A, Moses, S W, Peleg, N, Bashan, N

    Published in Pediatric research (01-07-1990)
    “…Neutrophil functions and glucose metabolism are known to be impaired in glycogen storage disease (GSD) Ib patients. The uptake of nonmetabolizing glucose…”
    Get full text
    Journal Article
  16. 16

    Neutropenia, neutrophil dysfunction, and inflammatory bowel disease in glycogen storage disease type Ib: Results of the European Study on Glycogen Storage Disease Type I by Visser, Gepke, Rake, Jan-Peter, Fernandes, John, Labrune, Philippe, Leonard, James V., Moses, Shimon, Ullrich, Kurt, Smit, G.Peter A.

    Published in The Journal of pediatrics (01-08-2000)
    “…Objective: To investigate the incidence, the severity, and the course of neutropenia, neutrophil dysfunction, and inflammatory bowel disease (IBD) in glycogen…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Dexamethasone and salbutamol in the treatment of acute wheezing in infants by Tal, A, Bavilski, C, Yohai, D, Bearman, J E, Gorodischer, R, Moses, S W

    Published in Pediatrics (Evanston) (01-01-1983)
    “…Thirty-two infants, aged 1 to 12 months, hospitalized with acute wheezing, were studied. They were randomly divided into four treatment groups of eight…”
    Get full text
    Journal Article
  19. 19

    A Recessive Contiguous Gene Deletion of Chromosome 2p16 Associated with Cystinuria and a Mitochondrial Disease by Parvari, Ruti, Brodyansky, Irena, Elpeleg, Orly, Moses, Shimon, Landau, Daniel, Hershkovitz, Eli

    Published in American journal of human genetics (01-10-2001)
    “…Deletions ranging from 100 Kb to 1 Mb—too small to be detected under the microscope—may still involve dozens of genes, thus causing microdeletion syndromes…”
    Get full text
    Journal Article
  20. 20